FOXO TECHNOLOGIES INC. Income (Loss) Attributable to Parent, before Tax
FOXO TECHNOLOGIES INC. (FOXO) reported Income (Loss) Attributable to Parent, before Tax of -$1.50 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2024-06-28
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for the quarter ending 2024-03-31 was -$1.50M.
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for the quarter ending 2023-12-31 was -$3.86M.
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for the quarter ending 2023-09-30 was -$3.66M.
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for the quarter ending 2023-06-30 was -$11.29M.
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for fiscal 2023 was -$26.45M.
- FOXO TECHNOLOGIES INC. income (loss) attributable to parent, before tax for fiscal 2022 was -$95.25M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month | Income (Loss) Attributable to Parent, before Tax 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$1.50M 10-Q · filed 2024-06-28 | -$5.36M derived: sum of 2 quarters · filed 2024-06-28 | -$9.02M derived: sum of 3 quarters · filed 2024-06-28 | -$20.32M derived: sum of 4 quarters · filed 2024-06-28 |
| 2023-12-31 | -$3.86M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$7.52M derived: sum of 2 quarters · filed 2024-06-06 | -$18.81M derived: sum of 3 quarters · filed 2024-06-06 | -$26.45M 10-K · filed 2024-06-06 |
| 2023-09-30 | -$3.66M 10-Q/A · filed 2024-06-04 | -$14.95M derived: sum of 2 quarters · filed 2024-06-04 | -$22.59M 10-Q/A · filed 2024-06-04 | -$40.91M derived: sum of 4 quarters · filed 2024-06-28 |
| 2023-06-30 | -$11.29M 10-Q · filed 2023-08-10 | -$18.93M 10-Q · filed 2023-08-10 | -$37.26M derived: sum of 3 quarters · filed 2024-06-28 | -$78.28M derived: sum of 4 quarters · filed 2024-06-28 |
| 2023-03-31 | -$7.64M 10-Q · filed 2024-06-28 | -$25.96M derived: sum of 2 quarters · filed 2024-06-28 | -$66.99M derived: sum of 3 quarters · filed 2024-06-28 | -$90.53M derived: sum of 4 quarters · filed 2024-06-28 |
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$59.35M derived: sum of 2 quarters · filed 2024-06-06 | -$82.89M derived: sum of 3 quarters · filed 2024-06-06 | -$95.25M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$41.03M 10-Q/A · filed 2024-06-04 | -$64.56M derived: sum of 2 quarters · filed 2024-06-04 | -$76.93M 10-Q/A · filed 2024-06-04 | -$60.29M derived: sum of 4 quarters · filed 2024-06-04 |
| 2022-06-30 | -$23.54M 10-Q · filed 2023-08-10 | -$35.91M 10-Q · filed 2023-08-10 | -$19.27M derived: sum of 3 quarters · filed 2023-08-10 | -$18.90M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$376.97K 10-Q · filed 2022-05-16 | $4.27M derived: sum of 2 quarters · filed 2022-05-16 | $4.64M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2021-12-31 | $4.65M 10-K · filed 2022-03-07 | $5.01M derived: sum of 2 quarters · filed 2022-03-07 | ||
| 2021-09-30 | $367.04K 10-Q · filed 2021-11-15 | $3.51M 10-Q · filed 2021-11-15 | ||
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-16 | $3.21M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$1.78M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |